Filtered By:
Condition: Pneumonia

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 13068 results found since Jan 2013.

Convalescent plasma from Norwegian blood donors to treat COVID-19
Tidsskr Nor Laegeforen. 2023 Jul 26;143(11). doi: 10.4045/tidsskr.22.0180. Print 2023 Aug 15.ABSTRACTBACKGROUND: At the start of the pandemic, the Norwegian Directorate of Health and Norwegian blood banks initiated the production of COVID-19 convalescent plasma within the framework of clinical studies. In this article we describe the blood donors who participated.MATERIAL AND METHOD: Blood donors who had recovered from COVID-19 were recruited to donate single donor plasma for the purpose of patient treatment. Data on the course of infection, leukocyte antibodies and antibody level against severe acute respiratory syndrome ...
Source: Tidsskrift for den Norske Laegeforening - August 17, 2023 Category: General Medicine Authors: Lise Sofie Haug Nissen-Meyer Tine Torsvik Steinsv åg Mona H øysæter Fenstad Ingvild Hausberg S ørvoll Marte Hvalryg Thomas Larsen Titze Karin Magnussen Gunn Kristoffersen Kathrine Margrethe Neuman Johnsen Abid Hussain Llohn Brita Hermundstad Lilja Syn Source Type: research

Subcutaneous emphysema, pneumomediastinum and pneumothorax in COVID-19 pneumonia —independent prognostic factors
AbstractThe ongoing coronavirus disease 2019 pandemic has created a substantial disease burden and morbidity. However, the development of subcutaneous emphysema, pneumomediastinum, and pneumothorax have been of rare occurrence and their significance in mortality has not been studied. In a retrospective single-institution observational study at a tertiary care centre in the northern part of India, we evaluated the occurrence of these complications and their relationship with mortality from 1 June 2020 to 30 November 2020. All coronavirus disease 2019 (COVID-19) patients developing subcutaneous emphysema, pneumomediastinum, ...
Source: Indian Journal of Thoracic and Cardiovascular Surgery - August 17, 2023 Category: Cardiovascular & Thoracic Surgery Source Type: research

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Intern Med. 2023 Aug 16. doi: 10.2169/internalmedicine.1648-23. Online ahead of print.ABSTRACTPulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four cases of EP potentially triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, all of which required systemic corticosteroid therapy. We herein report the first case of post-COVID-19 EP res...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Yumiko Misaki Yusuke Hayashi Masahiro Shirata Kazuhiro Terada Akihiko Yoshizawa Ryo Sakamoto Kohei Ikezoe Kiminobu Tanizawa Tomohiro Handa Toyohiro Hirai Source Type: research

Acute thrombotic occlusion involving three coronary arteries. A unique association with COVID ‐19 pneumonia
Proximal Left Anterior Descending artery (LAD) 100% thrombotic occlusion and distal Left circumflex artery (LCX) 100% thrombotic occlusion. B. distal Right Coronary artery (RCA) 100% thrombotic occlusion. C. Post-percutaneous coronary intervention to LAD and LCX Key Clinical MessageRespiratory viruses, particularly COVID-19, can be associated with severe cases of myocardial infarction (MI). Physicians should have a low threshold for MI in COVID-19 patients who present with persistent chest pain as MI in rapidly deteriorating cases can be missed. Prompt response includes both timely diagnosis and swift treatment.AbstractThe...
Source: Clinical Case Reports - August 16, 2023 Category: General Medicine Authors: Mhd Baraa Habib, Mohamed Salah Abdelghani, Ahmed Elyas, Anas A. Ashour, Mohammad Altermanini, Shahid Imran, Abdul Rahman Arabi Tags: CASE REPORT Source Type: research

Endogenous and Therapeutic 25-hydroxycholesterols May Worsen Early SARS-CoV-2 Pathogenesis in Mice
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).PMID:37578898 | DOI:10.1165/rcmb.2023-0007OC
Source: Mol Biol Cell - August 14, 2023 Category: Molecular Biology Authors: Michael B Fessler Jennifer H Madenspacher Paul J Baker Kerry L Hilligan Andrea C Bohrer Ehydel Castro Julie Meacham Shih-Heng Chen Reed F Johnson Jeffrey G McDonald Negin P Martin C J Tucker Debabrata Mahapatra Mark Cesta Katrin D Mayer-Barber Source Type: research

Radiologic Features of T10 Paravertebral Muscle Sarcopenia: Prognostic Factors in COVID-19
CONCLUSIONS: Easy to obtain and accurately calculated, radiologic features can provide a reliable alternative to laboratory methods for predicting survival in COVID-19. Thoracic muscles' CSA measurement in the level of the T10 vertebra, an acclaimed prognostic imaging assessment that relates directly to CT-SS and inflammatory markers in COVID-19 pneumonia, is a fairly specific tool for survival prognosis.PMID:37575354 | PMC:PMC10416190 | DOI:10.14740/jocmr4963
Source: Clin Med Res - August 14, 2023 Category: Research Authors: Georgios Schinas Vasiliki Dimakopoulou Konstantinos Dionysopoulos Georgia Fezoulidi Marianna Vlychou Katerina Vassiou Nikolaos K Gatselis Anna Samakidou Georgios Giannoulis Argyrios Tzouvelekis Markos Marangos Charalambos Gogos George N Dalekos Christina Source Type: research